Integrating Trauma-informed Care into Three, Distinct HIV Care Settings: Successes and Promising Practices
Integrating trauma-informed care (TIC) using an implementation science lens.
Resource (Conference Presentation) updated 09/14/2023
Integrating trauma-informed care (TIC) using an implementation science lens.
Resource (Conference Presentation) updated 09/14/2023
Overview of the updated Trauma-informed Approaches (TIA) Toolkit, which includes tools and assessment to support RWHAP parts in implementing TIA and centering healing and resilience.
Resource (Conference Presentation) updated 09/14/2023
Description of telehealth implementation through a clinic-deployed smartphone application.
Resource (Conference Presentation) updated 09/14/2023
Review of trauma-informed leadership and supervision as a strategy to re-think leadership and build equitable, trauma-informed, healing environments.
Resource (Conference Presentation) updated 09/14/2023
Resource updated 10/24/2023
Resource updated 05/11/2023
Resource updated 12/19/2023
Resource updated 10/18/2023
Resource updated 05/10/2023
Resource updated 06/27/2024
Resource from the RWHAP Best Practices Compilation updated on 11/13/2023
RWHAP Technical Assistance Provider updated on 07/09/2024
Resource from the RWHAP Best Practices Compilation updated on 11/01/2023
RWHAP Technical Assistance Provider updated on 02/27/2024
Session on a rural clinic's work and adjustments during COVID-19. Presentation from the Division of Community HIV/AIDS Programs (DCHAP) Business Day Meeting held at the 2022 National Ryan White Conference.
Resource (Conference Presentation) updated 09/14/2023
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023
Significant challenges exist in vaccinating people with HIV for COVID-19. Our RWPC program set out to implement and evaluate a vaccine initiative for COVID-19 for people with HIV. We achieved vaccine rates of 78 percent being fully vaccinated by December 1, 2021 and 30 percent having a third dose.
Resource (Conference Presentation) updated 09/14/2023
Review of rapid ART features to reduce time to ART from 7 to 1.6 days, including pre-visit benefits navigation, manufacturer discount cards, prescribing to in-house pharmacies, email distribution lists, and post-prescriptive follow-up.
Resource (Conference Presentation) updated 09/14/2023